Colombia vs Mauritania: HIV-positive TB patients on ART (antiretroviral therapy)
Colombia
68.0%
in 2024
Mauritania
69.0%
in 2023
Colombia rank
130th
Mauritania rank
128th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Colombia
- Mauritania
How they compare
Mauritania currently reports 69.0% against 68.0% in Colombia, a difference of 1.0%.
The two have swapped places 1 time across 8 shared years of data; in 2007 it was Colombia ahead.
Colombia ranks 130th and Mauritania ranks 128th of 144 countries.
Across the 3 decades both report, Colombia averaged higher in 1 and Mauritania in 2.
Head to head by decade
| Decade | Colombia | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 86.0% | 14.0% | Colombia |
| 2010s | 44.0% | 84.7% | 40.7% | Mauritania |
| 2020s | 57.8% | 81.0% | 23.2% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Colombia or Mauritania?
- Mauritania, at 69.0% against 68.0% in Colombia as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Colombia and Mauritania?
- 1.0%, with Mauritania ahead.
- How many years of comparable data are there for Colombia and Mauritania?
- 8 years are reported by both, from 2007 to 2023.
- How do Colombia and Mauritania rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Colombia ranks 130th and Mauritania ranks 128th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.